Trump administration says it secured new supplies of the drug for use against COVID-19
An ampule of remdesivir is pictured during a news conference at the University Hospital Eppendorf in Hamburg, Germany, on April 8, 2020. Ulrich Perrey/Pool via Reuters, file Photo
A California-based company is charging hundreds of dollars per vial for a drug it created that’s shown promise against COVID-19.
Gilead Sciences announced Monday it will begin to charge for remdesivir in July, which it previously donated for free to the United States and other countries.
Zachary Stieber
Senior Reporter
Zachary Stieber is a senior reporter for The Epoch Times based in Maryland. He covers U.S. and world news. Contact Zachary at [email protected]
